Sign up to save your podcasts
Or
Share Season 3: Episode 4 - US FDA’s Facilitated Regulatory Pathway and Their Significance
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Season 3: Episode 4 - US FDA’s Facilitated Regulatory Pathway and Their Significance
Expedited drug development pathways ensure the availability of treatment at the earliest. The US FDA’s facilitated Regulatory pathways give priority to innovators based on the nature of their innovation and more. Our experts discuss (i) Fastrack, (ii) Breakthrough Therapy, (iii) Accelerated Approval, and (iv) Priority Review and their impact on drug development timelines.
To know more about Season 3, visit https://www.freyrsolutions.com/regulatory-radio/season-3-us-market-entry
View all episodes
By Freyr SolutionsExpedited drug development pathways ensure the availability of treatment at the earliest. The US FDA’s facilitated Regulatory pathways give priority to innovators based on the nature of their innovation and more. Our experts discuss (i) Fastrack, (ii) Breakthrough Therapy, (iii) Accelerated Approval, and (iv) Priority Review and their impact on drug development timelines.
To know more about Season 3, visit https://www.freyrsolutions.com/regulatory-radio/season-3-us-market-entry